Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson Administration

Trial Profile

Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson Administration

Recruiting
Phase of Trial: Phase 0

Latest Information Update: 27 Nov 2015

At a glance

  • Drugs Regadenoson (Primary) ; Temozolomide
  • Indications Glioma
  • Focus Pharmacokinetics
  • Most Recent Events

    • 24 Nov 2015 Planned primary completion date changed from 1 Feb 2016 to 1 Jul 2016 as reported by ClinicalTrials.gov.
    • 26 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top